Nasdaq IPOs

Adagio Therapeutics, a Phase 1 biotech developing antibody therapies COVID-19 and other infectious diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Adagio Therapeutics' lead program, ADG20, has completed enrollment in a Phase 1 cl

Castle Creek Biosciences, a Phase 3 biotech developing cell-based gene therapies for rare diseases, filed on Friday with the SEC to raise up to $100 million.Castle Creek is focused on developing and commercializing disease-modifying therapies for patients suffering from rare dise

Golden Ventures Acquisition, a blank check company targeting the commodities space, filed on Friday with the SEC to raise up to $100 million.The Singapore-based company plans to raise $100 million by offering 10 million units at $10. Each unit consists of one share of common stoc

Dynacure, a French Phase 1/2 biotech developing therapies for neuromuscular diseases, did not price its IPO on Friday. The offering has been withdrawn for now. It had filed to raise $100 million by offering 6.3 million ADSs at a price range of $15 to $17.Dynacure is initially foc

Black Spade Acquisition, a blank check company targeting the entertainment industry in China, raised $150 million by offering 15 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50.Black Spade Acquisition is

Candel Therapeutics, a Phase 3 biotech developing oncolytic viral immunotherapies for cancer, announced terms for its IPO on Friday. The Needham, MA-based company plans to raise $85 million by offering 6.1 million shares at a price range of $13 to $15. At the midpoint of the pro

Xponential Fitness, a roll-up of franchised boutique fitness brands with over 1,750 studios in North America, announced terms for its IPO on Friday.The Irvine, CA-based company plans to raise $200 million by offering 13.3 million shares at a price range of $14 to $16. MSD Partner

StoneBridge Acquisition, a blank check company targeting "new economy sectors" in Asia Pacific, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50.The company is led by&nbs

Erasca, a Phase 2 biotech developing therapies for RAS/MAPK pathway-driven cancers, raised $300 million by offering 18.8 million shares at $16, the high end of the range of $14 to $16. The company offered 1.3 million more shares than anticipated. Erasca employs a modality-agnosti

Blend Labs, which provides a digital platform for lenders to offer mortgages and consumer loans, raised $360 million by offering 20 million shares at $18, the high end of the range of $16 to $18. Blend Labs' growing suite of products currently powers digital-first consumer j

TScan Therapeutics, a preclinical biotech developing engineered T cell cancer therapies, raised $100 million by offering 6.7 million shares at $15, the low end of the range of $15 to $17. The company had previously filed to offer 6.3 million shares, but increased the share offeri

Bridge Investment Group, a vertically-integrated real estate investment manager with $26 billion in AUM, raised $300 million by offering 18.8 million shares at $16, the midpoint of the $15 to $17 range. At pricing, Bridge commands a market value of $1.8 billion.Bridge Investment

Stevanato Group, an Italian supplier of glass vials, syringes, and other pharmaceutical containers, raised $672 million by offering 32 million shares (100% primary) at $21, the low end of the range. It previously planned to sell 40 million shares (70% primary) at a range of

Bilander Acquisition, a blank check company formed by True Wind Capital targeting the tech sector, raised $150 million by offering 15 million units at $10.Each unit consists of one share of common stock and one-fourth of a warrant, exercisable at $11.50. The company may raise an

Regencell Bioscience Holdings, which is developing formulations of traditional Chinese medicine for ADHD and autism, raised $22 million by offering 2.3 million shares at $9.50, within the range of $8.50 to $10.50.At pricing, the Hong Kong, China-based company commands a market va

Enphys Acquisition, a blank check company targeting renewable energy businesses in Ibero-America, filed on Thursday with the SEC to raise up to $250 million.The New York, NY-based company plans to raise $250 million by offering 25 million units at $10. Each unit consists of one s

Imago BioSciences, a Phase 2 biotech developing small molecules for bone marrow cancer and diseases, raised $134 million by offering 8.4 million shares at $16, the high end of the range of $14 to $16. The company plans to raise an additional $20 million in a concurrent priva

FinWise Bancorp, a Utah-based digital bank that offers loan and deposit services across the US, filed on Thursday with the SEC to raise up to $50 million.FinWise Bancorp is a bank holding company that operates through its wholly-owned subsidiary, FinWise Bank, a Utah state-charte

Abri SPAC I, a blank check company targeting FinTech and InsurTech businesses, filed on Thursday with the SEC to raise up to $50 million.The Beverly Hills, CA-based company plans to raise $50 million by offering 5 million units at $10. Each unit consists of one share of common st

DoubleDown Interactive, a leading developer and publisher of mobile- and web-based social casino games, officially withdrew its registration statement for an initial public offering on Thursday. It last filed to raise $86 million in June 2020 at a market cap of $777 million, befo